BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

842 related articles for article (PubMed ID: 18336927)

  • 1. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions.
    Bausch DG; Sprecher AG; Jeffs B; Boumandouki P
    Antiviral Res; 2008 Apr; 78(1):150-61. PubMed ID: 18336927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].
    Stock I
    Med Monatsschr Pharm; 2014 Sep; 37(9):324-30; quiz 331-2. PubMed ID: 25282746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marburg and Ebola--arming ourselves against the deadly filoviruses.
    Peters CJ
    N Engl J Med; 2005 Jun; 352(25):2571-3. PubMed ID: 15972860
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ebola and Marburg hemorrhagic fever viruses: update on filoviruses].
    Leroy E; Baize S; Gonzalez JP
    Med Trop (Mars); 2011 Apr; 71(2):111-21. PubMed ID: 21695865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of vaccines for Marburg hemorrhagic fever.
    Bausch DG; Geisbert TW
    Expert Rev Vaccines; 2007 Feb; 6(1):57-74. PubMed ID: 17280479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Threat of Marburg and Ebola viral haemorrhagic fevers in Africa.
    Tukei PM
    East Afr Med J; 1996 Jan; 73(1):27-31. PubMed ID: 8625857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of treatment strategies to combat Ebola and Marburg viruses.
    Paragas J; Geisbert TW
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug targets in infections with Ebola and Marburg viruses.
    Gene OG; Julia BE; Vanessa MR; Victoria WJ; Thomas GW; Lisa HE
    Infect Disord Drug Targets; 2009 Apr; 9(2):191-200. PubMed ID: 19275706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learned during active epidemiological surveillance of Ebola and Marburg viral hemorrhagic fever epidemics in Africa.
    Allaranga Y; Kone ML; Formenty P; Libama F; Boumandouki P; Woodfill CJ; Sow I; Duale S; Alemu W; Yada A
    East Afr J Public Health; 2010 Mar; 7(1):30-6. PubMed ID: 21413569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comments on the article "Marburg and Ebola virus infections in laboratory non-human primates: a literature review". Soren Schou and Axel Kornerup Hansen. Comparative Medicine, 2000. 50:108-123.
    Weber H
    Comp Med; 2000 Oct; 50(5):479-80. PubMed ID: 11099125
    [No Abstract]   [Full Text] [Related]  

  • 11. Filoviruses: recent advances and future challenges.
    Bray M; Pilch R
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):917-21. PubMed ID: 17181407
    [No Abstract]   [Full Text] [Related]  

  • 12. Lessons from nosocomial viral haemorrhagic fever outbreaks.
    Fisher-Hoch SP
    Br Med Bull; 2005; 73-74():123-37. PubMed ID: 16373655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ebola and Marburg viruses: the humans strike back].
    Alazard-Dany N; Ottmann Terrangle M; Volchkov V
    Med Sci (Paris); 2006 Apr; 22(4):405-10. PubMed ID: 16597410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marburg and Ebola virus infections in laboratory non-human primates: a literature review.
    Schou S; Hansen AK
    Comp Med; 2000 Apr; 50(2):108-23. PubMed ID: 10857001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of cyanovirin-N antiviral activity, by use of lentiviral vectors pseudotyped with filovirus envelope glycoproteins.
    Barrientos LG; Lasala F; Otero JR; Sanchez A; Delgado R
    J Infect Dis; 2004 Apr; 189(8):1440-3. PubMed ID: 15073681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa.
    Leroy EM; Gonzalez JP; Baize S
    Clin Microbiol Infect; 2011 Jul; 17(7):964-76. PubMed ID: 21722250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single shot against Ebola and Marburg virus.
    Baize S
    Nat Med; 2005 Jul; 11(7):720-1. PubMed ID: 16015361
    [No Abstract]   [Full Text] [Related]  

  • 18. Ebola and Marburg viruses: pathogenesis and development of countermeasures.
    Hensley LE; Jones SM; Feldmann H; Jahrling PB; Geisbert TW
    Curr Mol Med; 2005 Dec; 5(8):761-72. PubMed ID: 16375711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.
    Suschak JJ; Schmaljohn CS
    Hum Vaccin Immunother; 2019; 15(10):2359-2377. PubMed ID: 31589088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ebola and Marburg hemorrhagic fevers: neglected tropical diseases?
    MacNeil A; Rollin PE
    PLoS Negl Trop Dis; 2012 Jun; 6(6):e1546. PubMed ID: 22761967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.